000 | 01419 a2200421 4500 | ||
---|---|---|---|
005 | 20250516044728.0 | ||
264 | 0 | _c20111209 | |
008 | 201112s 0 0 eng d | ||
022 | _a1790-6245 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeidle, Ulrich H | |
245 | 0 | 0 |
_aSynthetic lethality-based targets for discovery of new cancer therapeutics. _h[electronic resource] |
260 |
_bCancer genomics & proteomics _c |
||
300 |
_a159-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aBenzamides |
650 | 0 | 4 |
_aDNA Repair _xgenetics |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aGenes, Tumor Suppressor |
650 | 0 | 4 | _aGenes, myc |
650 | 0 | 4 | _aGenes, p53 |
650 | 0 | 4 | _aGenes, ras |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein Kinases _xdrug effects |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aRetinoblastoma Protein _xgenetics |
650 | 0 | 4 |
_aVon Hippel-Lindau Tumor Suppressor Protein _xgenetics |
700 | 1 | _aMaisel, Daniela | |
700 | 1 | _aEick, Dirk | |
773 | 0 |
_tCancer genomics & proteomics _gvol. 8 _gno. 4 _gp. 159-71 |
|
999 |
_c20989852 _d20989852 |